Search Results 31-40 of 11943 for Rimegepant

  1. Yohannes Woldeamanuel, M.D. - Mayo Clinic Faculty Profiles

    ... rimegepant (Nurtec ODT) for endometriosis-associated pain (NCT07795125). Through patient-centered clinical trials evaluating multimodal and precise ...

  2. Apitegromab-mstn (intravenous route) - Side effects & uses - Mayo Clinic

    Apitegromab-mstn injection is used to treat spinal muscular atrophy (SMA) in patients who are currently receiving a survival motor neuron 2 (SMN2) targeted ...

  3. End-stage renal disease - Doctors and departments - Mayo Clinic

    When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

  4. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

  5. Pimavanserin (oral route) - Side effects & dosage - Mayo Clinic

    Description. Pimavanserin is used to treat hallucinations and delusions caused by Parkinson disease psychosis. It works in the brain to prevent ...

  6. Drugs and Supplements that Start with R - Mayo Clinic

    Rimegepant (oral route) · Rimexolone (ophthalmic route). Rimso-50. Also known as. Dimethyl sulfoxide (intravesical route). Rinvoq. Also known as. Upadacitinib ( ...

  7. Aprepitant (oral route) - Mayo Clinic

    Aprepitant capsules and oral suspension are used in combination with other medicines to prevent the nausea and vomiting that may occur during cancer treatment ( ...

  8. Lemborexant (oral route) - Mayo Clinic

    Lemborexant is used to treat insomnia (sleeping problems). It belongs to the group of medicines called central nervous system (CNS) depressants. These medicines ...

  9. Leuprolide acetate (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Leuprolide acetate injection is used to treat central precocious puberty (CPP), a condition which causes early puberty in males (before 9 years of age) and ...

  10. An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...